EASTERN AFRICA SOLUTION CENTRE
CURRENT ACTIVE COUNTRIES
ABOUT US
ARC in Eastern Africa supports ministries of health in this region to strengthen their supply chains to improve availability of medicines. The region also has a Solution Centre that supports the regions to achieve the organisational mission.
OUR INITIATIVES
Supporting Kenya's antiretroviral regimen transition
ARC performed an independent advisory role to shape the overall TLD transition project and brokered additional expert resources from Novo Nordisk and a local private sector consultant to support the initiative.
Leveraging private sector engagement to support medicine availability in Kenya
ARC has been working with the federation’s supply chain technical working group to engage the Ministry of Health in a collaborative platform where it can draw on insights and capabilities from the private sector.
Strengthening visibility across the public health supply chain in Kenya
ARC created dashboards that allow the Ministry of Health to easily monitor healthcare product inventory levels of down to the facility level.
Supporting the development of strategic components of supply chain strategy in Kenya
ARC and Johnson & Johnson collaborated to support the costing and implementation plan activities to inform the annual and multi-year operational budgets for Kenya’s health products and technologies supply chain.
Uganda Differentiated Service Delivery (DSD)
Differentiated Service Delivery (DSD) is the supply chain strategy and interventions that support differentiated service delivery and care. ARC will support the Ministry of Health’s AIDS Control Programme to continue to evolve and transform Uganda’s DSD strategy and model. ARC anticipates a multi-year partnership over several phases with the focus of phase 1 being to develop and optimize the target DSD model for Uganda.
TLD Transition
Kenya has around 1.1 million people on ART and is embarking on a similar transition. As in South Africa, there are context-specific transition challenges. For example, there are multiple existing regimens and risks of expiry and wastages of stock due to poor visibility of stock levels and consumption at lower levels of healthcare. ARC will support NASCOP in refining the current Kenyan supply chain plan for transitioning from Tenofovir /Lamivudine/ Efavirenz to TLD in a way that addresses these challenges, as well as systematically identifying the lessons learned.